Tamsulosin - characterization and alteration in benign prostatic hypertophy

Author： Maruyama K. Nakamura T. Yoshihara T. Fukutomi J. Sugiyama K. Hattorim K. Ohnuki T. Watanabe K. Nagatomo T.

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.31, Iss.4, 1998-10, pp. : 597-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dutasteride/Tamsulosin: In Benign Prostatic Hyperplasia

By Keating Gillian M.

Drugs & Aging, Vol. 29, Iss. 5, 2012-05 ,pp. : 405-419

Adis International

Access to resources Recommend Favorite

Efficacy of Low-Dose Tamsulosin in Chinese Patients with Symptomatic Benign Prostatic Hyperplasia

By Li N-C.

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 781-787

Adis International

Access to resources Recommend Favorite

Tamsulosin and floppy iris syndrome in benign prostatic hyperplasia patients

By Tiwari Atul

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 443-446

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Low-Dose Tamsulosin on Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Nonblind Multicentre Korean Study

By Choal Hee Park

Clinical Drug Investigation, Vol. 24, Iss. 1, 2004-01 ,pp. : 41-47

Adis International

Access to resources Recommend Favorite

Combined medical treatment using dutasteride and tamsulosin for lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Djavan Bob Handl Markus Johannes Dianat Saeid

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2535-2547

Informa Healthcare

Access to resources Recommend Favorite